In T2D inadequately controlled with metformin, orforglipron reduced HbA(1c) more than dapagliflozin at 40 wk

Annals of internal medicine · 2026 Nov 3 · Htay T, ACP Journal Club Editorial Team at McMaster University et

By Maren Holt · Senior Reporter, GLP-1

Nov 2 19:00 ETSource: Annals of internal medicine

From the source

In T2D inadequately controlled with metformin, orforglipron reduced HbA(1c) more than dapagliflozin at 40 wk
Annals of internal medicine · 2026 Nov 3 · Htay T, ACP Journal Club Editorial Team at McMaster University et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42970798/